EXTENDED COLLABORATION AND LICENSE AGREEMENTExtended Collaboration and License Agreement • September 27th, 2007 • Athersys, Inc / New • Pharmaceutical preparations • New York
This Extended Collaboration and License Agreement (the “Agreement”) is made and entered into as of January 1, 2006 (the “Effective Date”), by and between Athersys, Inc., a Delaware corporation having its principal offices at 3201 Carnegie Avenue, Cleveland, Ohio 44115 (“Athersys”), and Bristol-Myers Squibb Company, a Delaware corporation having offices at Route 206 and Province Line Road, Princeton, New Jersey 08543 (“BMS”). Athersys and BMS may be referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT No. 3 TO EXTENDED COLLABORATION AND LICENSE AGREEMENTExtended Collaboration and License Agreement • May 14th, 2012 • Athersys, Inc / New • Pharmaceutical preparations
THIS AMENDMENT NO. 3 (this “Amendment No. 3”), dated as of January 31, 2012 (the “Effective Date”), by and between ABT Holding Company, formerly operating as “Athersys, Inc.” prior to a name change, a Delaware corporation having its principal offices at 3201 Carnegie Avenue, Cleveland, Ohio 44115 (“Athersys”), and Bristol-Myers Squibb Company, a Delaware corporation having offices at Route 206 and Province Line Road, Princeton, New Jersey 08543 (“BMS”). Athersys and BMS may be referred to herein individually as a “Party” and collectively as the “Parties.”
